Martha Rook

Martha Rook is an experienced executive with a strong background in operations and technical leadership in the biotechnology sector. As the Chief Operating Officer at Delcath Systems since March 2024, Martha Rook previously served as Chief Technical Operations Officer at insitro and Sigilon Therapeutics, Inc. Martha Rook has held various senior roles at MilliporeSigma, where leadership efforts focused on gene editing and novel modalities, overseeing the development of tools and services for cell, gene, and RNA therapies. Martha Rook's academic credentials include a Ph.D. in Biochemistry from the Massachusetts Institute of Technology and a BS in Chemistry from Texas A&M University.